N Mark Lampert

Affiliations

• Other at 4D Molecular Therapeutics Inc. (FDMT), 2024-11-13
• Other at Third Harmonic Bio Inc. (THRD), 2024-10-31
• Large Shareholder at Eledon Pharmaceuticals Inc. (ELDN), 2024-10-31
• Large Shareholder, Director at Moonlake Immunotherapeutics (MLTX), 2024-10-08
• Director, Other at Kymera Therapeutics Inc. (KYMR), 2024-08-22
• Large Shareholder, Director at Olema Pharmaceuticals Inc. (OLMA), 2024-06-18
• Director, Other at Rain Oncology Inc. (RAIN), 2024-01-30
• Large Shareholder at Allakos Inc. (ALLK), 2024-01-26
• Other at Point Biopharma Global Inc. (PNT), 2023-12-20
• Large Shareholder at Repare Therapeutics Inc. (RPTX), 2023-11-17
• Large Shareholder at Engene Holdings Inc. (ENGN), 2023-11-13
• Large Shareholder, Director, Other at Cti Biopharma Corp (CTIC), 2023-06-28
• Large Shareholder at Pieris Pharmaceuticals Inc. (PIRS), 2023-05-22
• Large Shareholder, Director at Xoma Corp (XOMA), 2023-05-19
• Large Shareholder at Structure Therapeutics Inc. (GPCR), 2023-05-13
• Large Shareholder at Cullinan Oncology Inc. (CGEM), 2023-01-19
• Large Shareholder at Essa Pharma Inc. (EPIX), 2022-07-21
• Large Shareholder at Verastem Inc. (VSTM), 2022-02-08
• Large Shareholder at Merus N.v. (MRUS), 2021-10-09
• Large Shareholder at Five Prime Therapeutics Inc. (FPRX), 2021-03-08
• Other at Infinity Pharmaceuticals Inc. (INFI), 2021-02-19
• Other at Cytomx Therapeutics Inc. (CTMX), 2021-02-19
• Other at Ideaya Biosciences Inc. (IDYA), 2021-02-04
• Other at Cytokinetics Inc (CYTK), 2020-12-11
• Large Shareholder at Glycomimetics Inc (GLYC), 2020-11-06
• Large Shareholder at Principia Biopharma Inc. (PRNB), 2020-08-20
• Large Shareholder at Calithera Biosciences Inc. (CALA), 2020-05-26
• Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2019-06-12
• Large Shareholder at Immune Design Corp. (IMDZ), 2018-12-05
• Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2018-06-20
• Large Shareholder at Arqule Inc (ARQL), 2018-06-01
• Large Shareholder at Xenon Pharmaceuticals Inc. (XENE), 2018-03-29
• Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2017-11-27
• Other at Capstone Therapeutics Corp. (CAPS), 2017-07-18
• Large Shareholder at Nivalis Therapeutics Inc. (NVLS), 2017-06-22
• Large Shareholder, Director at Cascadian Therapeutics Inc. (ONTY), 2016-06-27
• Other at Chemocentryx Inc. (CCXI), 2015-11-05
• Other at Catalyst Biosciences Inc. (TRGT), 2015-08-21
• Other at Array Biopharma Inc (ARRY), 2014-07-10
• Other at Ligand Pharmaceuticals Inc (LGND), 2014-03-26
• Other at Regado Biosciences Inc (RGDO), 2014-03-25
• Large Shareholder at Palatin Technologies Inc (PTN), 2014-03-03
• Large Shareholder at Rigel Pharmaceuticals Inc (RIGL), 2013-11-20
• Other at Neurocrine Biosciences Inc (NBIX), 2012-02-10
• Other at Kent International Holdings Inc (KENT), 2011-12-29
• Large Shareholder at Icagen Inc (ICGN), 2011-09-09
• Large Shareholder at Celera Corp (CRA), 2011-05-17
• Large Shareholder at Supergen Inc (SUPG), 2010-04-21
• Large Shareholder at Facet Biotech Corp (FACT), 2010-02-09